Xellia: Xellia Pharmaceuticals becomes member of Medicines for Europe

Xellia Pharmaceuticals, a manufacturer of specialty anti-infective treatments, has become a member of Medicines for Europe. Medicines for Europe represents the generic, biosimilar and value-added pharmaceutical industries in Europe. Member companies are responsible for providing the essential medicines that European patients, healthcare professionals and healthcare systems rely on. Image caption: Image credit: Xellia Pharmaceuticals read more